Differential susceptibility of resting CD4(+) T lymphocytes to a T-tropic and a macrophage (M)-tropic human immunodeficiency virus type 1 is associated with their surface expression of CD38 molecules
- PMID: 11163640
- DOI: 10.1016/s0168-1702(00)00220-3
Differential susceptibility of resting CD4(+) T lymphocytes to a T-tropic and a macrophage (M)-tropic human immunodeficiency virus type 1 is associated with their surface expression of CD38 molecules
Abstract
Recent evidence has accumulated which definitively shows that chemokine receptors CCR5 and CXCR4 play an essential role as coreceptors for human immunodeficiency virus type 1 (HIV-1) infection. Flow cytometric analysis permitted us to detect CD38, a surface marker of early differentiation, as well as activation of T cells, on about half of healthy donor-derived CD4(+) T cells. In this study, we focused on the susceptibility of CD38(+) and CD38(-) subsets of CD4(+) T cells to HIV-1 infection with different coreceptor tropisms. About 20% of peripheral blood mononuclear cell-derived resting CD4(+) T cells were recovered into the CD38(+) subset fraction by panning with a monoclonal antibody to CD38. Most of the cells in this CD38(high) fraction also expressed CD45RA and CD62L at higher intensities compared with those of CD38(low) fraction. CCR5(+) T cells predominated in the CD38(-) subset, although cell surface expression of CD4 and CXCR4 was almost similar between both subsets. This difference was consistent with a significantly higher susceptibility of the CD38(-) subset to a macrophage (M)-tropic HIV-1 strain. In contrast, it was shown that a T-tropic strain of HIV-1 could replicate more efficiently in the CD38(+) subset, although viral adsorption rates were similar between both subsets. Thus, the differential susceptibility of CD4(+) T cells to M(-) and T-tropic HIV-1 was associated with their surface expression of CD38.
Similar articles
-
Resting CD4(+) T cells with CD38(+)CD62L(+) produce interleukin-4 which contributes to enhanced replication of T-tropic human immunodeficiency virus type 1.Virology. 2002 Feb 1;293(1):94-102. doi: 10.1006/viro.2001.1272. Virology. 2002. PMID: 11853403
-
Interleukin-4 up-regulates T-tropic human immunodeficiency virus type 1 transcription in primary CD4+ CD38+ T-lymphocyte subset.Microbiol Immunol. 2005;49(2):155-65. doi: 10.1111/j.1348-0421.2005.tb03715.x. Microbiol Immunol. 2005. PMID: 15722601
-
Increased CCR5 and CXCR4 expression in Ethiopians living in Israel: environmental and constitutive factors.Clin Immunol. 2001 Jul;100(1):107-17. doi: 10.1006/clim.2001.5040. Clin Immunol. 2001. PMID: 11414751
-
CD38 in T- and B-cell functions.Chem Immunol. 2000;75:146-68. doi: 10.1159/000058767. Chem Immunol. 2000. PMID: 10851783 Review. No abstract available.
-
CD38 in health and disease.Chem Immunol. 2000;75:218-34. doi: 10.1159/000058771. Chem Immunol. 2000. PMID: 10851787 Review. No abstract available.
Cited by
-
Positive and negative aspects of the human immunodeficiency virus protease: development of inhibitors versus its role in AIDS pathogenesis.Microbiol Mol Biol Rev. 2000 Dec;64(4):725-45. doi: 10.1128/MMBR.64.4.725-745.2000. Microbiol Mol Biol Rev. 2000. PMID: 11104817 Free PMC article. Review.
-
Differential susceptibility epidemic models.J Math Biol. 2005 Jun;50(6):626-44. doi: 10.1007/s00285-004-0301-7. Epub 2004 Dec 20. J Math Biol. 2005. PMID: 15614550
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Research Materials